Provided by Tiger Fintech (Singapore) Pte. Ltd.

CF Industries Holdings Inc

74.81
+0.71000.96%
Volume:294.74K
Turnover:22.04M
Market Cap:12.45B
PE:11.10
High:75.28
Open:74.34
Low:74.34
Close:74.10
Loading ...

If I Could Buy Only 1 Growth Stock, This Would Be It

Motley Fool
·
10 Mar

3 Magnificent Growth Stocks to Buy in March

Motley Fool
·
08 Mar

CF Industries put volume heavy and directionally bearish

TIPRANKS
·
08 Mar

Vertex Pharmaceuticals announces MHRA approval of ALYFTREK for CF

TIPRANKS
·
07 Mar

Vertex Announces UK MHRA Approval of ALYFTREK® (Deutivacaftor/Tezacaftor/Vanzacaftor), a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire
·
07 Mar

CF Industries Holdings, Inc. (CF): Among the Worst Farmland and Agriculture Stocks to Buy According to Short Sellers

Insider Monkey
·
07 Mar

CF Industries Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
06 Mar

Arcturus Therapeutics to Present at Leerink’s Global Healthcare Conference 2025

Business Wire
·
06 Mar

CF Industries Is Maintained at Equal-Weight by Barclays

Dow Jones
·
05 Mar

Barclays Adjusts Price Target on CF Industries to $95 From $100, Keeps Equalweight Rating

MT Newswires Live
·
05 Mar

5 Top Stocks to Buy in March

Motley Fool
·
04 Mar

Sionna Therapeutics: Promising NBD1 Stabilizers Poised to Challenge Vertex in the $11 Billion CF Market

TIPRANKS
·
04 Mar

CF Industries Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Mar

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

Insider Monkey
·
04 Mar

CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
01 Mar

4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones

GlobeNewswire
·
01 Mar

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

GlobeNewswire
·
28 Feb

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Business Wire
·
28 Feb

Press Release: BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

Dow Jones
·
26 Feb

CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
26 Feb